Genesis Accountable Care Organization

Public Report

Location

1227 East Rusholme Street
Davenport Iowa 52803

Primary Contact

Dr William Langley
langleyw@genesishealth.com
563-421-2801

Composition

A hospital employing ACO professionals 

ACO Participants

  • Genesis Health System
  • Genesis Medical Center, Aledo
  • Genesis Senior Living, Aledo
  • GenVentures, Inc
  • Navinchandra Dadhaniya MD
  • Community Health Care, Inc.

ACO Governing Body

Board Officers

  • Andrew Andresen MD, Voting Member and Chair, Genesis Health Group
  • Harold Miller MD, Voting Member and Secretary, Genesis Health Group
  • Mark Rogers, Voting Member and Treasurer, Genesis Health System 

Board Members

  • Steve Aguilar MD, Voting Member and Chair of Medical Management Committee, Genesis Health Group
  • Brian Anderson, DO, Voting Member, Genesis Health Group
  • Tom Bowman, Voting Member, Community Health Care, Inc
  • Christopher Crome MD, Voting Member, Genesis Health Group
  • Douglas Cropper, Voting Member, Genesis Health System
  • Kurt Andersen, MD, Voting Member, Genesis Health Group
  • Micheal Schreck MD, Voting Member, Genesis Health Group
  • Rose Warhank MD, Voting Member and Chair of Care Model Committee, Genesis Health Group
  • George Wahlig, Voting Member, Medicare Beneficiary Representative

ACO Committees and Key Leadership Personnel

  • Kurt Andersen MD, Medical Director
  • Rose Warhank MD, Chair of Care Model Committee
  • Harold Miller MD, Chair of Finance and Contracting Committee
  • Steve Aguilar MD, Chair of Medical Management Committee

Amount of Shared Savings/Losses

  • Performance Year 1: $0
  • Performance Year 2: $0
  • Performance Year 3: TBD

How Shared Savings Are Distributed

  • Reinvest in infrastructure - 15%
  • Distribution to ACO Participants: 85%

    • Primary Care Professionals: 50%
    • Specialists: 0%
    • Hospitals: 35%

Quality Performance Results 

2012 Performance ACO Mean
ACO-8 14.8 15.42
ACO-9 0.85 1.13
ACO-10 1.47 1.09
ACO-11 55.84% 59.87% 

2013 Performance ACO Mean
ACO-8 14.43  14.90
ACO-9 0.96 1.17
ACO-10 1.42 1.20
ACO-11 68.83% 66.21% 

2014 Performance ACO Mean
Domain: Patient/Caregiver Experience

Getting Timely Care, Appointments, and Information (ACO-1) 83.08 80.13
How Well Your Doctors Communicate (ACO-2) 93.24 92.39
Patients’ Rating of Doctor (ACO-3) 92.86 91.58
Access to Specialists (ACO-4) 86.88 83.97
Health Promotion and Education (ACO-5) 52.75 58.29
Shared Decision Making (ACO-6) 72.95 74.60
Health Status/Functional Status (ACO-7) 72.60 71.10
Domain: Care Coordination/Patient Safety
Risk Standardized, All Condition Readmissions (ACO-8) 14.54 15.15
ASC Admissions: COPD or Asthma in Older Adults (ACO-9) 0.86 1.08
ASC Admission: Heart Failure (ACO-10) 1.30 1.19
Percent of Primary Care Providers who Qualified for EHR
Incentive Payment (ACO-11)
72.73% 76.71
Medication Reconciliation (ACO-12) 98.65% 82.61
Falls: Screening for Fall Risk (ACO-13) 14.14% 45.60
Domain: Preventive Health
Influenza Immunization (ACO-14) 67.00% 57.51
Pneumococcal Vaccination (ACO-15) 68.30% 55.03
Adult Weight Screening and Follow-up (ACO-16) 86.61% 66.75
Tobacco Use Assessment and Cessation Intervention (ACO-17) 94.12% 86.79
Depression Screening (ACO-18) 21.21% 39.27
Colorectal Cancer Screening (ACO-19) 64.05% 56.14
Mammography Screening (ACO-20) 72.37% 61.41
Proportion of Adults who had blood pressure screened in
past 2 years (ACO-21)
85.87% 60.24
Domain: At Risk Population
Beneficiaries with diabetes who met of all the following criteria:
Hemoglobin A1c Control (HbA1c) (<8 percent) (ACO-22)
79.25% 25.41
Beneficiaries with diabetes who met of all the following criteria:
Low Density Lipoprotein (LDL) (< 100 mg/dL) (ACO-23)
64.71%
Beneficiaries with diabetes who met of all the following criteria:
Blood Pressure (BP) < 140/90 (ACO-24)
82.03%
Beneficiaries with diabetes who met of all the following criteria:
Tobacco Non-Use (ACO-25)
86.44%
Beneficiaries with diabetes who met of all the following criteria:
Aspirin Use (ACO-26)
80.32%
Percent of beneficiaries with diabetes whose HbA1c in
poor control (>9 percent) (ACO-27)
11.44% 20.35
Percent of beneficiaries with hypertension whose BP < 140/90 (ACO-28) 78.35% 68.02
Percent of beneficiaries with IVD with complete lipid profile
and LDL control < 100mg/dl (ACO-29)
63.18% 57.29
Percent of beneficiaries who use Aspirin or other antithrombotic (ACO-30) 89.19% 80.79
Beta-Blocker Therapy for LVSD (ACO-31) 90.72% 82.71
Percent of beneficiaries with CAD who met all of the following criteria:
Drug Therapy for Lowering LDL-Cholesterol (ACO-32)
87.27% 66.90
Percent of beneficiaries with CAD who met all of the following criteria:
(ACE) Inhibitor or (ARB) Therapy for Patients with CAD abd Diabetes
and/or (LVSD) (ACO-33)
80.43%

Last Updated: September 2015